4.6 Review

Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma

Related references

Note: Only part of the references are listed.
Article Pathology

Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements

Diede A. G. van Bladel et al.

Summary: The clonality analysis plays an important role in diagnosing classic Hodgkin lymphoma, especially in cases with atypical presentation or histology resembling T cell lymphoma and patients with recurrent disease. The development of a novel NGS-based assay has significantly improved the detection of clonal gene rearrangements in cHL cases, particularly in formalin-fixed paraffin-embedded tissue specimens, demonstrating increased sensitivity and performance compared to conventional methods.

MODERN PATHOLOGY (2022)

Article Medical Laboratory Technology

Assessment of Clonotypic Rearrangements and Minima Residual Disease in Lymphoid Malignancies A Large Cancer Center Experience Using clonoSEQ

Mohammad O. Hussaini et al.

Summary: The clonoSEQ assay is a valuable and sensitive tool for monitoring MRD in patients with plasma cell and lymphoid malignancies, as well as assisting in the diagnosis of CTCL.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2022)

Article Oncology

Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors

Jouni Kujala et al.

Summary: The study evaluated the concordance between cfDNA and tumor DNA genetic profiles, showing that liquid biopsy can reflect the heterogeneity and clonal evolution of BC, potentially identifying driver variants and therapeutic targets that may be missed in tumor DNA sequencing. Liquid biopsy may aid in the early detection of metastatic BC and support clinical decision-making, despite observed discordance between the two sources of DNA.

CANCERS (2022)

Article Hematology

Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study

Vincent Camus et al.

Summary: The study demonstrates the significance of ctDNA analysis as a liquid biopsy and minimal residual disease tool in the management of cHL patients. By using a targeted NGS panel for fast analysis and monitoring the changes in ctDNA after chemotherapy, it helps to assess early treatment response and genetic features of cHL.

HAEMATOLOGICA (2021)

Review Biology

Liquid Biopsy, ctDNA Diagnosis through NGS

Chen Lin et al.

Summary: Liquid biopsy with ctDNA profiling by next-generation sequencing shows great promise in clinical oncology, with advantages of less invasiveness and sampling bias compared to tissue biopsy. NGS technologies are becoming more popular for ctDNA profiling, paving the way for precision medicine in cancer diagnosis and management.

LIFE-BASEL (2021)

Editorial Material Hematology

Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma

David M. Kurtz

HAEMATOLOGICA (2021)

Article Cell Biology

GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner

Zhizhou Xia et al.

Summary: The study reveals that palmitoylation of GNA13 plays a crucial role in regulating its tumor suppressor function and negatively regulating BCL2 expression in GCB-DLBCL cells. BCL2 inhibitors have been found to effectively kill GNA13-deficient GCB-DLBCL cells in a cell-based chemical screen. Targeting GNA13's palmitoylation enhances the sensitivity of GCB-DLBCL to BCL2 inhibitors, suggesting a potential combination therapy approach for treating GCB-DLBCL with wild-type GNA13.

CELL DEATH & DISEASE (2021)

Review Oncology

Signaling pathways of EBV-induced oncogenesis

Yin Luo et al.

Summary: Epstein-Barr virus is closely associated with multiple human cancers, mainly lymphomas and carcinomas. The virus can induce oncogenesis through activating various signaling pathways in host cells.

CANCER CELL INTERNATIONAL (2021)

Review Oncology

Molecular biology of Hodgkin lymphoma

Marc A. Weniger et al.

Summary: Classical Hodgkin lymphoma (cHL) has unique biological features such as the orchestration of a complex microenvironment by HRS cells, the major role of Epstein-Barr virus in lymphomagenesis, and the defining interplay of genetic lesions and cellular origin. These factors contribute to the constitutive activation of multiple signaling pathways in cHL.

LEUKEMIA (2021)

Article Multidisciplinary Sciences

Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma

Tomohiro Aoki et al.

Summary: LR-CHL has a unique CD4* helper T cell subset characterized by high expression of CXCL13 and PD-1. PD-1*CXCL13* T cells are significantly enriched in LR-CHL compared to other CHL subtypes, and their abundance in the TME is significantly associated with shorter progression-free survival. These findings suggest the importance of the CXCL13/CXCR5 axis and PD-1*CXCL13* T cells as a treatment target in LR-CHL.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Oncology

Genomic Landscape of Hodgkin Lymphoma

Magdalena M. Brune et al.

Summary: Hodgkin lymphoma (HL) consists mainly of reactive cells with only a few cancer cells, making high-throughput molecular investigation challenging for a long time. Recently developed methods have allowed for the analysis of genetic alterations in Hodgkin and Reed-Sternberg (HRS) or lymphocyte predominant (LP) cells, which impact immune evasion, proliferation, and evasion of programmed cell death. Understanding these molecular mechanisms is crucial for prognosis, prediction, and improving therapy, especially for patients with recurrent or treatment-resistant disease.

CANCERS (2021)

Review Chemistry, Medicinal

Cell-Free DNA for the Management of Classical Hodgkin Lymphoma

Vincent Camus et al.

Summary: Cell-free DNA (cfDNA) testing is a promising liquid biopsy tool for lymphoma detection, especially in classical Hodgkin lymphoma (cHL); cfDNA levels are associated with clinical features and can serve as a tool for therapeutic response evaluation; cfDNA analysis helps in monitoring the treatment efficacy of cHL.

PHARMACEUTICALS (2021)

Article Hematology

The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA

Lieselot Buedts et al.

Summary: The study investigated the genomic copy number aberrations in classical Hodgkin lymphoma (cHL) by analyzing circulating cell-free DNA (cfDNA) from newly diagnosed mostly early-stage cHL patients. The results showed high frequencies of CNAs in cfDNA at diagnosis, with some novel recurrent CNAs identified. Additionally, ctDNA concentration was associated with disease characteristics and decreased rapidly upon treatment initiation, with persistent CNAs predicting increased probability of relapse.

BLOOD ADVANCES (2021)

Review Pathology

How I Diagnose Angioimmunoblastic T-Cell Lymphoma

Yi Xie et al.

Summary: AITL, a subtype of peripheral T-cell lymphoma derived from T-follicular helper cells, poses diagnostic challenges due to its wide clinical and histopathologic spectrum. Diagnostic tools and molecular studies play crucial roles in aiding accurate diagnosis and differential diagnosis.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Hematology

Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping

Miguel Alcoceba et al.

Summary: The study utilizing liquid biopsy with ctDNA revealed genetic features of HL patients, identifying several genes related to poor prognosis. The number of variants in high-quality ctDNA samples was associated with disease severity in patients.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Article Oncology

Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin Lymphoma

Alessandra Venanzi et al.

Summary: The study found that clonal hematopoiesis could be present in the tissue of classic Hodgkin lymphoma (cHL), give rise to the tumor clone, and spread to large parts of its microenvironment. Even when massive, clonal hematopoiesis does not always lead to the neoplastic clone of multiple myeloid and lymphoid neoplasms occurring in the same patient.

BLOOD CANCER DISCOVERY (2021)

Article Medicine, Research & Experimental

In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection

Sophia Sobesky et al.

Summary: Cell-free DNA sequencing is a powerful strategy for understanding the genomic landscape of Hodgkin's lymphoma and for ultra-sensitive disease monitoring. Comprehensive evaluation of genotypes and minimal residual disease can predict treatment response and progression, leading to improved treatment guidance and relapse prediction.
Article Oncology

Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma

Ann-Kathrin Desch et al.

LEUKEMIA (2020)

Review Oncology

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer

Valli De Re et al.

INFECTIOUS AGENTS AND CANCER (2020)

Review Medicine, General & Internal

Hodgkin Reed-Sternberg-Like Cells in Non-Hodgkin Lymphoma

Paola Parente et al.

DIAGNOSTICS (2020)

Article Pathology

ClonoSEQ assay for the detection of lymphoid malignancies

Anna Monter et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)

Review Immunology

Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis

Huali Yin et al.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2019)

Review Oncology

Hodgkin Lymphoma: A Review and Update on Recent Progress

Satish Shanbhag et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Review Pharmacology & Pharmacy

Capturing tumor heterogeneity and clonal evolution in solid cancers using circulating tumor DNA analysis

Nieves Perdigones et al.

PHARMACOLOGY & THERAPEUTICS (2017)

Review Biology

Epstein-Barr virus-associated lymphomas

Claire Shannon-Lowe et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)

Review Oncology

Liquid biopsies come of age: towards implementation of circulating tumour DNA

Jonathan C. M. Wan et al.

NATURE REVIEWS CANCER (2017)

Review Cell Biology

The role of T cells in the microenvironment of Hodgkin lymphoma

Frederik Wein et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2016)

Article Pathology

High-grade Transformation of Low-grade B-cell Lymphoma Pathology and Molecular Pathogenesis

Rose Lou Marie C. Agbay et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)

Article Oncology

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Margaretha G. M. Roemer et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Pathology

Reliable Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue Using Single Molecule Tags

Astrid Eijkelenboom et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2016)

Article Oncology

Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?

Sally L. Glaser et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)

Article Medical Laboratory Technology

Molecular Analysis of IGH and Incomplete IGH D-J Clonality Gene Rearrangements in Hodgkin Lymphoma Malignancies

Saeid Ghorbian et al.

CLINICAL LABORATORY (2015)

Article Biochemistry & Molecular Biology

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

Giulia Siravegna et al.

NATURE MEDICINE (2015)

Article Biochemistry & Molecular Biology

Age-related mutations associated with clonal hematopoietic expansion and malignancies

Mingchao Xie et al.

NATURE MEDICINE (2014)

Article Biochemistry & Molecular Biology

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Aaron M. Newman et al.

NATURE MEDICINE (2014)

Article Medicine, General & Internal

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Giulio Genovese et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Oncology

Relapsed Hodgkin Lymphoma: Management Strategies

Francesca Montanari et al.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2014)

Article Oncology

Plasma Cell-Free DNA in Paediatric Lymphomas

Lara Mussolin et al.

JOURNAL OF CANCER (2013)

Article Pathology

Follicular Peripheral T-cell Lymphoma Expands the Spectrum of Classical Hodgkin Lymphoma Mimics

Julien Moroch et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)

Article Medicine, Research & Experimental

Hodgkin lymphoma

Ralf Küppers et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Oncology

Clonal Relationship of Classical Hodgkin Lymphoma and Its Recurrences

Ellen C. Obermann et al.

CLINICAL CANCER RESEARCH (2011)

Review Oncology

Transformation of Indolent B-Cell Lymphomas

Silvia Montoto et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Biochemistry & Molecular Biology

EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis

Ting-Yun Liu et al.

MOLECULAR CANCER (2010)

Review Pathology

Pathogenesis of Classical and Lymphocyte-Predominant Hodgkin Lymphoma

Roland Schmitz et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)

Article Immunology

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

Roland Schmitz et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Article Biochemistry & Molecular Biology

Detection of immunoglobulin heavy chain gene rearrangements in classic Hodgkin lymphoma using commercially available BIOMED-2 primers

Deborah J. Chute et al.

DIAGNOSTIC MOLECULAR PATHOLOGY (2008)

Review Oncology

Molecular pathogenesis of Hodgkin's lymphoma

D Re et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Oncology

Classical Hodgkin lymphoma is associated with frequent gains of 17q

DTY Chui et al.

GENES CHROMOSOMES & CANCER (2003)

Article Oncology

Genetic instability in Hodgkin's lymphoma

D Re et al.

ANNALS OF ONCOLOGY (2002)

Article Immunology

Rare occurrence of classical Hodgkin's disease as a T cell lymphoma

M Müschen et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2000)